Laney Dawn A, Fernhoff Paul M
Emory Department of Human Genetics, 2165 North Decatur Road, Decatur, GA 30033, USA.
J Genet Couns. 2008 Feb;17(1):79-83. doi: 10.1007/s10897-007-9128-x. Epub 2008 Jan 3.
Fabry disease is an X-linked lysosomal storage condition caused by a deficiency of alpha-galactosidase A. In order to determine the average number of family members who are diagnosed with Fabry disease following the diagnosis of a proband, four lysosomal storage disease centers across the United States reviewed the completed pedigrees of their Fabry disease patients. In addition, data from three Fabry disease families from other centers were submitted by patients directly. The pedigree review found 74 probands (54 males and 20 females) who had 357 diagnosed family members, of which 223 were female (60.5%) and 146 were male (39.5%). Analysis found that, on average, there were five family members diagnosed with Fabry disease for every proband. Now that enzyme replacement therapy (ERT) is available for the treatment of Fabry disease, this finding emphasizes the need for all health care professionals to ensure a detailed pedigree has been constructed for each patient affected by Fabry disease and to encourage testing and evaluation of all at-risk family members.
法布里病是一种由α-半乳糖苷酶A缺乏引起的X连锁溶酶体贮积症。为了确定在先证者被诊断后被诊断为法布里病的家庭成员的平均数量,美国的四个溶酶体贮积症中心审查了其法布里病患者完整的家系图谱。此外,来自其他中心的三个法布里病家庭的数据由患者直接提交。家系图谱审查发现74位先证者(54名男性和20名女性)有357名被诊断的家庭成员,其中223名是女性(60.5%),146名是男性(39.5%)。分析发现,平均每位先证者有五名家庭成员被诊断为法布里病。鉴于现在有酶替代疗法(ERT)可用于治疗法布里病,这一发现强调了所有医疗保健专业人员需要确保为每位受法布里病影响的患者构建详细的家系图谱,并鼓励对所有高危家庭成员进行检测和评估。